NASDAQ:PRTA

Prothena News Headlines

$24.62
+0.96 (+4.06 %)
(As of 05/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$23.74
$25.45
50-Day Range
$21.74
$28.24
52-Week Range
$9.25
$28.66
Volume276,345 shs
Average Volume426,697 shs
Market Capitalization$984.95 million
P/E RatioN/A
Dividend YieldN/A
Beta1.71

Headlines

Prothena (NASDAQ PRTA) News Headlines Today

SourceHeadline
Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c) - GlobeNewswireProthena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c) - GlobeNewswire
globenewswire.com - May 7 at 8:46 PM
Prothena Co. plc (NASDAQ:PRTA) Expected to Post FY2022 Earnings of ($2.30) Per ShareProthena Co. plc (NASDAQ:PRTA) Expected to Post FY2022 Earnings of ($2.30) Per Share
americanbankingnews.com - May 7 at 11:36 AM
Puma (PBYI) Beats on Q1 Earnings, Ups Nerlynx Sales View - NasdaqPuma (PBYI) Beats on Q1 Earnings, Ups Nerlynx Sales View - Nasdaq
nasdaq.com - May 7 at 10:46 AM
Ultragenyx (RARE) Q1 Loss Narrows Y/Y, Revenues Beat Estimates - NasdaqUltragenyx (RARE) Q1 Loss Narrows Y/Y, Revenues Beat Estimates - Nasdaq
nasdaq.com - May 5 at 11:20 AM
Prothena (PRTA) to Release Quarterly Earnings on TuesdayProthena (PRTA) to Release Quarterly Earnings on Tuesday
americanbankingnews.com - May 5 at 10:56 AM
Prothena to Report First Quarter 2021 Financial Results on May 11th - Yahoo FinanceProthena to Report First Quarter 2021 Financial Results on May 11th - Yahoo Finance
finance.yahoo.com - May 5 at 12:18 AM
Prothena to Report First Quarter 2021 Financial Results on May 11th - GlobeNewswireProthena to Report First Quarter 2021 Financial Results on May 11th - GlobeNewswire
globenewswire.com - May 4 at 7:18 PM
Prothena to Report First Quarter 2021 Financial Results on May 11thProthena to Report First Quarter 2021 Financial Results on May 11th
finance.yahoo.com - May 4 at 7:17 PM
What Kind Of Shareholders Own Prothena Corporation plc (NASDAQ:PRTA)? - NasdaqWhat Kind Of Shareholders Own Prothena Corporation plc (NASDAQ:PRTA)? - Nasdaq
nasdaq.com - May 3 at 7:13 PM
Prothena PLC Stock Is Estimated To Be Possible Value Trap - Yahoo FinanceProthena PLC Stock Is Estimated To Be Possible Value Trap - Yahoo Finance
finance.yahoo.com - May 2 at 11:52 PM
Earnings Preview: Prothena (PRTA) Q1 Earnings Expected to Decline - Yahoo FinanceEarnings Preview: Prothena (PRTA) Q1 Earnings Expected to Decline - Yahoo Finance
finance.yahoo.com - April 28 at 2:51 PM
Earnings Preview: Prothena (PRTA) Q1 Earnings Expected to DeclineEarnings Preview: Prothena (PRTA) Q1 Earnings Expected to Decline
finance.yahoo.com - April 28 at 2:51 PM
$170,000.00 in Sales Expected for Prothena Co. plc (NASDAQ:PRTA) This Quarter$170,000.00 in Sales Expected for Prothena Co. plc (NASDAQ:PRTA) This Quarter
americanbankingnews.com - April 26 at 1:54 AM
-$0.80 EPS Expected for Prothena Co. plc (NASDAQ:PRTA) This Quarter-$0.80 EPS Expected for Prothena Co. plc (NASDAQ:PRTA) This Quarter
americanbankingnews.com - April 24 at 4:16 PM
Global Parkinsons Disease Drug Forecast and Market Analysis to 2029: High Opportunities and High Risks for Disease-Modifying Therapies Entering the PD Market - ResearchAndMarkets.com - Business WireGlobal Parkinson's Disease Drug Forecast and Market Analysis to 2029: High Opportunities and High Risks for Disease-Modifying Therapies Entering the PD Market - ResearchAndMarkets.com - Business Wire
businesswire.com - April 23 at 8:54 AM
What’s Next For Prothena Stock After A 9% Rise This Week? - ForbesWhat’s Next For Prothena Stock After A 9% Rise This Week? - Forbes
forbes.com - April 19 at 9:11 AM
Prothena Presents Phase 1 Study Results of PRX004 in Oral Presentation at AAN 2021 - GlobeNewswireProthena Presents Phase 1 Study Results of PRX004 in Oral Presentation at AAN 2021 - GlobeNewswire
globenewswire.com - April 18 at 6:57 PM
Prothena Presents Phase 1 Study Results of PRX004 in Oral Presentation at AAN 2021Prothena Presents Phase 1 Study Results of PRX004 in Oral Presentation at AAN 2021
finance.yahoo.com - April 18 at 6:56 PM
Prothena Co. plc (NASDAQ:PRTA) Given Average Rating of "Buy" by BrokeragesProthena Co. plc (NASDAQ:PRTA) Given Average Rating of "Buy" by Brokerages
americanbankingnews.com - April 18 at 6:22 AM
Parkinsons Disease - Global Drug Forecast and Market Analysis to 2029 - GlobeNewswireParkinson's Disease - Global Drug Forecast and Market Analysis to 2029 - GlobeNewswire
globenewswire.com - April 16 at 10:37 AM
Parkinsons Disease - Global Drug Forecast and Market Analysis to 2029 - BenzingaParkinson's Disease - Global Drug Forecast and Market Analysis to 2029 - Benzinga
benzinga.com - April 16 at 5:37 AM
Prothena Announces PRX004 Phase 1 Study Results Selected for Emerging Science Oral Presentation at AAN 2021 - Yahoo FinanceProthena Announces PRX004 Phase 1 Study Results Selected for Emerging Science Oral Presentation at AAN 2021 - Yahoo Finance
finance.yahoo.com - April 15 at 5:01 PM
Prothena Announces PRX004 Phase 1 Study Results Selected for Emerging Science Oral Presentation at AAN 2021Prothena Announces PRX004 Phase 1 Study Results Selected for Emerging Science Oral Presentation at AAN 2021
finance.yahoo.com - April 15 at 5:01 PM
Prothena Co. plc (NASDAQ:PRTA) Short Interest UpdateProthena Co. plc (NASDAQ:PRTA) Short Interest Update
americanbankingnews.com - April 15 at 7:42 AM
Prothena (NASDAQ:PRTA) Trading 5.5% Higher Prothena (NASDAQ:PRTA) Trading 5.5% Higher
americanbankingnews.com - April 13 at 2:34 PM
Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo FinanceProthena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
finance.yahoo.com - April 7 at 6:29 PM
Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - April 7 at 6:29 PM
Prothena Corp. (PRTA) Announces Appointment of Hideki Garren, MD, PhD, as CMO - StreetInsider.comProthena Corp. (PRTA) Announces Appointment of Hideki Garren, MD, PhD, as CMO - StreetInsider.com
streetinsider.com - April 5 at 11:41 PM
Prothena names new medical chief - Seeking AlphaProthena names new medical chief - Seeking Alpha
seekingalpha.com - April 5 at 6:40 PM
Prothena Announces Appointment of Hideki Garren, MD, PhD, as Chief Medical OfficerProthena Announces Appointment of Hideki Garren, MD, PhD, as Chief Medical Officer
finance.yahoo.com - April 5 at 6:40 PM
What Type Of Shareholders Make Up Prothena Corporation plcs (NASDAQ:PRTA) Share Registry? - Yahoo FinanceWhat Type Of Shareholders Make Up Prothena Corporation plc's (NASDAQ:PRTA) Share Registry? - Yahoo Finance
finance.yahoo.com - March 29 at 10:50 PM
What Type Of Shareholders Make Up Prothena Corporation plcs (NASDAQ:PRTA) Share Registry?What Type Of Shareholders Make Up Prothena Corporation plc's (NASDAQ:PRTA) Share Registry?
finance.yahoo.com - March 29 at 5:48 PM
Prothena (PRTA) Stock Jumps 16.8%: Will It Continue to Soar? - Yahoo FinanceProthena (PRTA) Stock Jumps 16.8%: Will It Continue to Soar? - Yahoo Finance
finance.yahoo.com - March 25 at 12:47 PM
Prothena Shows Market Leadership With Jump To 94 RS Rating - Investors Business DailyProthena Shows Market Leadership With Jump To 94 RS Rating - Investor's Business Daily
investors.com - March 25 at 12:47 PM
Prothena (PRTA) Stock Jumps 16.8%: Will It Continue to Soar?Prothena (PRTA) Stock Jumps 16.8%: Will It Continue to Soar?
finance.yahoo.com - March 25 at 12:47 PM
Prothena Corporation plc: Prothena Announces Proposed Offering of Ordinary SharesProthena Corporation plc: Prothena Announces Proposed Offering of Ordinary Shares
finanznachrichten.de - March 25 at 7:46 AM
Prothena Corporation plc: Prothena Announces Pricing of Public Offering of 3,500,000 Ordinary SharesProthena Corporation plc: Prothena Announces Pricing of Public Offering of 3,500,000 Ordinary Shares
finanznachrichten.de - March 25 at 7:46 AM
Prothena closes nearly 17% higher after pricing offering - Seeking AlphaProthena closes nearly 17% higher after pricing offering - Seeking Alpha
seekingalpha.com - March 24 at 8:40 PM
Prothena Announces Pricing of Public Offering of 3,500,000 Ordinary Shares - Yahoo FinanceProthena Announces Pricing of Public Offering of 3,500,000 Ordinary Shares - Yahoo Finance
finance.yahoo.com - March 24 at 8:40 PM
Prothena Announces Pricing of Public Offering of 3,500,000 Ordinary SharesProthena Announces Pricing of Public Offering of 3,500,000 Ordinary Shares
finance.yahoo.com - March 24 at 10:39 AM
Prothena Announces Proposed Offering of Ordinary Shares - GlobeNewswireProthena Announces Proposed Offering of Ordinary Shares - GlobeNewswire
globenewswire.com - March 23 at 7:37 PM
Prothena Announces Proposed Offering of Ordinary SharesProthena Announces Proposed Offering of Ordinary Shares
finance.yahoo.com - March 23 at 7:37 PM
Form PRE 14A PROTHENA CORP PUBLIC For: May 18 - StreetInsider.comForm PRE 14A PROTHENA CORP PUBLIC For: May 18 - StreetInsider.com
streetinsider.com - March 15 at 7:09 PM
Why Is Prothena (PRTA) Up 46.8% Since Last Earnings Report? - Yahoo FinanceWhy Is Prothena (PRTA) Up 46.8% Since Last Earnings Report? - Yahoo Finance
finance.yahoo.com - March 14 at 8:42 AM
Why Is Prothena (PRTA) Up 46.8% Since Last Earnings Report? - NasdaqWhy Is Prothena (PRTA) Up 46.8% Since Last Earnings Report? - Nasdaq
nasdaq.com - March 13 at 5:43 PM
The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmons FDA Review, Alzheimers Data From Prothena - BenzingaThe Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena - Benzinga
benzinga.com - March 11 at 9:12 AM
Prothena Corporation plc: Prothena to Hold Investor Webcast to Review Three Oral Presentations from AD/PD 2021Prothena Corporation plc: Prothena to Hold Investor Webcast to Review Three Oral Presentations from AD/PD 2021
finanznachrichten.de - March 8 at 10:09 PM
Prothena to Hold Investor Webcast to Review Three Oral Presentations from AD/PD 2021 - GlobeNewswireProthena to Hold Investor Webcast to Review Three Oral Presentations from AD/PD 2021 - GlobeNewswire
globenewswire.com - March 8 at 5:08 PM
Prothena to Hold Investor Webcast to Review Three Oral Presentations from AD/PD 2021Prothena to Hold Investor Webcast to Review Three Oral Presentations from AD/PD 2021
finance.yahoo.com - March 8 at 5:08 PM
UPDATE: RBC Capital Upgrades Prothena Corp (PRTA) to Outperform - StreetInsider.comUPDATE: RBC Capital Upgrades Prothena Corp (PRTA) to Outperform - StreetInsider.com
streetinsider.com - February 26 at 8:55 AM
This page was last updated on 5/8/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.